European annals of allergy and clinical immunology最新文献

筛选
英文 中文
Profile of patients attending a pediatric allergic clinic during COVID-19 pandemic-related lockdown: how many children could have been approached with telemedicine? 新冠肺炎流行病相关封锁期间在儿科过敏诊所就诊的患者简介:有多少儿童可以接受远程医疗?
IF 2.3
European annals of allergy and clinical immunology Pub Date : 2023-11-01 Epub Date: 2023-07-18 DOI: 10.23822/EurAnnACI.1764-1489.305
A Ertugrul, E Ulusoy Severcan, H Arslan, I Bostancı
{"title":"Profile of patients attending a pediatric allergic clinic during COVID-19 pandemic-related lockdown: how many children could have been approached with telemedicine?","authors":"A Ertugrul, E Ulusoy Severcan, H Arslan, I Bostancı","doi":"10.23822/EurAnnACI.1764-1489.305","DOIUrl":"10.23822/EurAnnACI.1764-1489.305","url":null,"abstract":"","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9830562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kounis syndrome: an underestimated emergency. 库尼斯综合征:一种被低估的紧急情况。
IF 2.3
European annals of allergy and clinical immunology Pub Date : 2023-11-01 Epub Date: 2022-07-18 DOI: 10.23822/EurAnnACI.1764-1489.260
G Zisa, A Panero, A Re, M G Mennuni, G Patti, M Pirisi
{"title":"Kounis syndrome: an underestimated emergency.","authors":"G Zisa, A Panero, A Re, M G Mennuni, G Patti, M Pirisi","doi":"10.23822/EurAnnACI.1764-1489.260","DOIUrl":"10.23822/EurAnnACI.1764-1489.260","url":null,"abstract":"<p><strong>Summary: </strong><b>Background.</b> Kounis syndrome (KS) is defined as a rare cause of an acute coronary syndrome associated with systemic allergic reactions. To establish the prevalence of KS among the patients with diagnosis of anaphylaxis, we described clinical features, cardiological and allergological outcomes of patients evaluated in our allergy outpatient clinic. <b>Methods.</b> A retrospective study was carried out in the Allergy Unit of Novara hospital, from January 2008 to March 2020. Skin tests and in vitro tests were performed with suspected etiological agents. <b>Results.</b> We found 9 adults with KS (2%) out of 444 subjects who had experienced anaphylactic reactions (4/9 to Hymenoptera stings, 5/9 to drugs). <b>Conclusions.</b> The present study highlights the importance of suspicion of KS that appears not so uncommon in patients with anaphylaxis. KS seems to be a rare disease because unrecognized in diagnosis of anaphylaxis.</p>","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40517181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Nodular regenerative hyperplasia in CVID patients: could low-dose oral glucocorticoids be part of the solution? CVID患者的结节性再生性增生:低剂量口服糖皮质激素可能是解决方案的一部分吗?
IF 2.3
European annals of allergy and clinical immunology Pub Date : 2023-11-01 Epub Date: 2022-03-18 DOI: 10.23822/EurAnnACI.1764-1489.251
R Sousa eSilva, S Pereira da Silva, R Luís, C Baldaia, S L Silva
{"title":"Nodular regenerative hyperplasia in CVID patients: could low-dose oral glucocorticoids be part of the solution?","authors":"R Sousa eSilva, S Pereira da Silva, R Luís, C Baldaia, S L Silva","doi":"10.23822/EurAnnACI.1764-1489.251","DOIUrl":"10.23822/EurAnnACI.1764-1489.251","url":null,"abstract":"","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46954489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Chronic spontaneous urticaria: from the hunt for causes and pathogenesis to the identification of different endotypes. 慢性自发性荨麻疹:从寻找病因和发病机制到鉴定不同的内型。
IF 2.3
European annals of allergy and clinical immunology Pub Date : 2023-11-01 Epub Date: 2023-07-27 DOI: 10.23822/EurAnnACI.1764-1489.307
R Asero, A Tedeschi
{"title":"Chronic spontaneous urticaria: from the hunt for causes and pathogenesis to the identification of different endotypes.","authors":"R Asero, A Tedeschi","doi":"10.23822/EurAnnACI.1764-1489.307","DOIUrl":"10.23822/EurAnnACI.1764-1489.307","url":null,"abstract":"<p><strong>Summary: </strong>The hunt for the causes and pathogenic mechanisms involved in chronic spontaneous urticaria (CSU) has engaged clinicians and scientists for decades. Although not all aspects of the disease are defined, our knowledge has now improved to the point that we can consider CSU as an umbrella clinical phenotype under which several different endotypes probably exist. The present article will briefly summarize the fascinating history of the progress in our knowledge of this disease.</p>","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9876788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical evaluation of subcutaneous immunotherapy with a polymerized molecular allergoid of Alt a 1 in patients with allergic rhinoconjunctivitis and/or allergic asthma caused by the mould Alternaria alternata. Altera 1聚合分子变应原皮下免疫治疗由Alternaria alternata霉菌引起的过敏性鼻结膜炎和/或过敏性哮喘患者的临床评价。
IF 2.3
European annals of allergy and clinical immunology Pub Date : 2023-11-01 Epub Date: 2022-09-01 DOI: 10.23822/EurAnnACI.1764-1489.267
Á Ferrer Torres
{"title":"Clinical evaluation of subcutaneous immunotherapy with a polymerized molecular allergoid of Alt a 1 in patients with allergic rhinoconjunctivitis and/or allergic asthma caused by the mould <i>Alternaria alternata</i>.","authors":"Á Ferrer Torres","doi":"10.23822/EurAnnACI.1764-1489.267","DOIUrl":"10.23822/EurAnnACI.1764-1489.267","url":null,"abstract":"<p><strong>Summary: </strong>This is a retrospective analysis of the clinical evolution of 14 patients diagnosed with allergic rhinoconjunctivitis (AR) and/or allergic asthma (AA) caused by <i>Alternaria alternata</i>, who were attended by the allergology service of Vega Baja Hospital of Orihuela (Alicante, Spain). The purpose was to assess the clinical impact and safety of 1-year of subcutaneous immunotherapy with a polymerized molecular allergoid of Alt a 1. Impact of the treatment on allergic diseases (mean number AR/AA episodes and ARIA/GINA classifications), changes in symptoms and prescribed medication, change in the global subjective clinical status of patients and satisfaction with the treatment were also evaluated. Adverse reactions were also recorded and analyzed. After 1-year of treatment, fewer AR and AA episodes (p less than 0.05) and improvements in ARIA/GINA classifications were observed. Significant improvements of symptoms (p less than 0.05) and a resulting general reduction of the medication prescribed was also detected. Improvements in the global subjective clinical status and good satisfaction rates were observed. Only 1 patient presented a local and not clinically relevant adverse reaction. The treatment showed promising effects with a significant improvement in the clinical status of all patients with a good safety profile.</p>","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40335703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Clinical severity of LTP syndrome is associated with an expanded IgE repertoire, FDEIA, FDHIH, and LTP mono reactivity. LTP综合征的临床严重程度与扩大的IgE库、FDEIA、FDHIH和LTP单反应性有关。
IF 2.3
European annals of allergy and clinical immunology Pub Date : 2023-09-15 DOI: 10.23822/EurAnnACI.1764-1489.314
E Scala, D Abeni, V Villella, D Villalta, L Cecchi, V Pravettoni, M Giani, E Caprini, R Asero
{"title":"Clinical severity of LTP syndrome is associated with an expanded IgE repertoire, FDEIA, FDHIH, and LTP mono reactivity.","authors":"E Scala,&nbsp;D Abeni,&nbsp;V Villella,&nbsp;D Villalta,&nbsp;L Cecchi,&nbsp;V Pravettoni,&nbsp;M Giani,&nbsp;E Caprini,&nbsp;R Asero","doi":"10.23822/EurAnnACI.1764-1489.314","DOIUrl":"https://doi.org/10.23822/EurAnnACI.1764-1489.314","url":null,"abstract":"<p><strong>Summary: </strong><b>Background.</b> LTP allergy is often a challenge for clinicians. We evaluated a multiplex diagnostic approach with diverse cofactors to stratify LTP syndrome risk. <b>Methods.</b> Of the 1,831 participants screened with 'Allergy Explorer-ALEX-2', 426 had reactions to at least one LTP. Data was gathered and recorded via an electronic database. <b>Results.</b> Reactivity to peach Pru p 3 was found in 77% of individuals with LTP allergy. Higher levels of specific IgE and concurrent sensitization to more than 5 molecules (50% of all LTP-sensitised participants, 62% of symptomatic cases) were significantly associated with an increased risk of severe reactions (p = 0.001). Several cofactors, either alone or in combination, also influenced patients' clinical outcomes. Some cofactors increased the risk of severe reactions, such as mono reactivity to LTP in 44.6% of cases (p = 0.001), FDEIA in 10.8% of patients (p = 0.001), and FDNIH in 11.5% (p = 0.005). On the other hand, reactivity to PR10 (24.2%; p = 0.001), profilin hypersensitivity (10.3%; p = 0.001), and/or atopic dermatitis (16.7%; p = 0.001) had a mitigating effect on symptom severity. <b>Conclusions.</b> Clinical severity of LTP syndrome is associated with an expanded IgE repertoire in terms of the number of LTP components recognized and increased IgE levels in individual molecules. Ara h 9, Cor a 8, and Mal d 3 showed the strongest association with clinical severity. In addition, several cofactors may either exacerbate (FDEIA, FDHIH, and LTP monoreactivity) or ameliorate (atopic dermatitis and co-sensitization to profilin and/or PR10) individual patient outcomes. These factors may be utilized for the daily clinical management of LTP syndrome.</p>","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10242276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypersensitivity to lipoic acid. 对硫辛酸过敏。
IF 2.3
European annals of allergy and clinical immunology Pub Date : 2023-09-06 DOI: 10.23822/EurAnnACI.1764-1489.310
F Marchi, A Carabelli
{"title":"Hypersensitivity to lipoic acid.","authors":"F Marchi,&nbsp;A Carabelli","doi":"10.23822/EurAnnACI.1764-1489.310","DOIUrl":"https://doi.org/10.23822/EurAnnACI.1764-1489.310","url":null,"abstract":"","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10516232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-effectiveness analysis of grass pollen specific immunotherapy in children with allergic rhinitis compared to the standard of care symptomatic treatment in Portugal. 草花粉特异性免疫疗法治疗儿童过敏性鼻炎的成本效益分析与葡萄牙标准护理症状治疗的比较。
IF 2.3
European annals of allergy and clinical immunology Pub Date : 2023-09-01 Epub Date: 2021-12-17 DOI: 10.23822/EurAnnACI.1764-1489.240
M Farraia, I Paciência, F Castro Mendes, J Cavaleiro Rufo, L Delgado, A Moreira
{"title":"Cost-effectiveness analysis of grass pollen specific immunotherapy in children with allergic rhinitis compared to the standard of care symptomatic treatment in Portugal.","authors":"M Farraia,&nbsp;I Paciência,&nbsp;F Castro Mendes,&nbsp;J Cavaleiro Rufo,&nbsp;L Delgado,&nbsp;A Moreira","doi":"10.23822/EurAnnACI.1764-1489.240","DOIUrl":"10.23822/EurAnnACI.1764-1489.240","url":null,"abstract":"<p><strong>Summary: </strong><b>Background.</b> Cost-effectiveness studies evaluating allergen immunotherapy (AIT) in children are scarce. We aim to compare the cost-effectiveness of subcutaneous (SCIT) and sublingual immunotherapy (SLIT) against standard-of-care (SOC) treatment in children with grass pollen allergic rhinitis. <b>Methods.</b> We created a Markov model to compare the three strategies over a 10-year horizon. SOC was the reference to calculate the incremental cost-effectiveness ratio (ICER). Deterministic and probabilistic sensitivity analysis were used to assess models' uncertainty. <b>Results.</b> We obtained an ICER of € 12,605 and € 6,318 for SLIT and SCIT, respectively. In sensitivity analysis, SCIT was more cost-effective than SLIT. <b>Conclusions.</b> AIT is cost-effective in children with grass pollen allergic rhinitis, especially for the subcutaneous route.</p>","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10212370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atopic dermatitis in adolescents with acne vulgaris. 青少年寻常痤疮的特应性皮炎。
IF 2.3
European annals of allergy and clinical immunology Pub Date : 2023-09-01 Epub Date: 2022-01-26 DOI: 10.23822/EurAnnACI.1764-1489.244
S Todo Bom Costa, C Tapadinhas, M L Sampaio
{"title":"Atopic dermatitis in adolescents with acne vulgaris.","authors":"S Todo Bom Costa,&nbsp;C Tapadinhas,&nbsp;M L Sampaio","doi":"10.23822/EurAnnACI.1764-1489.244","DOIUrl":"10.23822/EurAnnACI.1764-1489.244","url":null,"abstract":"Atopic dermatitis (AD) is a chronic skin disease characterized by severe pruritus, erythema, edema, crusting, excoriation, lichenification and skin dryness. AD is often diagnosed during childhood, though the onset of symptoms may occur at any time. Lesions in older children and adults are usually located in flexural areas along with the head and neck. Facial involvement is also common in AD, not only in children but additionally in adolescents [1]. This inflammatory disease is characterized by skin microbial dysbiosis and barrier dysfunction. Initial inflammation has a T2 profile in response to allergens, which is later amplified by skin barrier breaking and reduction of antimicrobial peptides. This promotes skin pathogens growth (mainly Staphylococcus aureus) and the evolution to a T2, T1 and T17 pattern [2, 3]. AD is often associated with other atopic diseases such as rhinitis and asthma.","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10147666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is polyethylene glycol allergy a real contraindication to COVID-19 mRNA vaccines? 聚乙二醇过敏是新冠肺炎mRNA疫苗的真正禁忌症吗?
IF 2.3
European annals of allergy and clinical immunology Pub Date : 2023-09-01 Epub Date: 2022-05-19 DOI: 10.23822/EurAnnACI.1764-1489.253
A Zancanaro, F RIzzo, R Dittadi
{"title":"Is polyethylene glycol allergy a real contraindication to COVID-19 mRNA vaccines?","authors":"A Zancanaro,&nbsp;F RIzzo,&nbsp;R Dittadi","doi":"10.23822/EurAnnACI.1764-1489.253","DOIUrl":"10.23822/EurAnnACI.1764-1489.253","url":null,"abstract":"","PeriodicalId":11890,"journal":{"name":"European annals of allergy and clinical immunology","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10212391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信